Navigation Links
Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
Date:4/28/2010

BOCA RATON, Fla. April 28 /PRNewswire/ -- The X-GRAFT™ device is fashioned from solid human cortical bone, and is designed to acutely treat degenerative conditions of the spine. Utilizing the benefits of a minimal-exposure surgical procedure, the X-GRAFT™ is implanted into the interspinous space to provide stabilization of the spine, with minimal disturbance to the surrounding tissue. This is the first to market in a series of minimally invasive devices currently in development at Binder Biomedical and a key component of the MLIFF™ (Minimal - Lumbar, Interspinous, Facet Fusion) procedure.

Lawrence Binder, President of Binder Biomedical, Inc. commented: "The robust patent-pending design of the X-GRAFT™ device makes it an excellent option for stabilization of the lumbar spine following a decompression. The benefits of this system are evident from the favorable feedback we've received from our users. By offering a full range of sizes, as well as a comprehensive set of precision instruments, the X-GRAFT™ device has the unique ability to accommodate varying patient anatomy, while using minimal exposure, and fewer steps than traditional techniques."

The X-GRAFT™ device is procured and manufactured to exacting specifications by the University of Miami Tissue Bank (UMTB). This non-profit organization is the first civilian tissue bank in the U.S. and a university owned and operated tissue bank. UMTB is a comprehensive world-class facility, which conducts rigorous screening, recovery, autopsies, processing and packaging for all donors. Implantation of the 100th X-GRAFT™ is expected by the end of next month. Plans to expand national distributions are already underway, along with a full launch of the X-GRAFT™ device across the U.S. by the third quarter 2010. For more information on the X-GRAFT™ device please contact: sales@bindermed.com

Binder Biomedical, Inc. is a privately held medical device company located in Boca Raton, Florida. Founded on the basis of combining quality engineering with surgeon innovation, BBI provides surgeons with the highest quality medical devices for the treatment of complex orthopedic and neurological spinal disorders. Our development efforts are concentrated on products which incorporate advanced minimal exposure techniques, with the goal of providing better overall patient care. For more information about Binder Biomedical, Inc. please visit their website at:  www.bindermed.com


'/>"/>
SOURCE Binder Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
2. Competitive Technologies Selects RF
3. Binder as Public Relations Agency of Record
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 2017 Companion animal ... in pets such as canine, avian and feline. ... types such as Attenuated Live Vaccines, Conjugate Vaccines, ... and Recombinant Vaccines. Attenuated live vaccines are derived ... which have been weakend under laboratory conditions. Conjugate ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group leased ... is developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company ... life-threatening diseases that have been underserved by scientific ... therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... , April 18, 2017 Viverae ® , ... announce the integration of IBM ® Watson Campaign ... deliver targeted communications for a personalized experience. Through digital ... on their health in real time. The enhanced experience ... most to members, wherever they are in their journey ...
Breaking Medicine Technology:
(Date:4/25/2017)... (PRWEB) , ... April 25, ... ... based in Newport Beach, California, committed to raising awareness for Duchenne muscular ... results from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental ... with dental fear and require sedation to receive dental care. The doctors offer three ... procedures, from hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... in unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as ... premier society for this important science. , The Teratology Society ...
Breaking Medicine News(10 mins):